Austria - Healthcare, Regulatory and Reimbursement Landscape

Austria - Healthcare, Regulatory and Reimbursement Landscape

  • September 2021 •
  • 184 pages •
  • Report ID: 6153507 •
  • Format: PDF
Austria - Healthcare, Regulatory and Reimbursement Landscape

The analyst has released its latest report, “Austria - Healthcare, Regulatory and Reimbursement Landscape”.The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Austria.

It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure.Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.

It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts.

The Austrian healthcare system ranks ninth in the world, driven by new emerging technologies for diagnostic procedures, personalized medical treatment, and healthcare IT.The rapidly aging population, unhealthy lifestyle, and advancement in pharmaceutical technology, are the main factors driving the growth of the pharmaceutical market in Austria.

The Austrian pharmaceutical market, based on pharmaceutical production value, increased from €2.61B in 2012 to €3.31B in 2019 at a Compound Annual Growth Rate (CAGR) of 3.45%. In terms of US Dollars, the market increased from $3.36B in 2012 to $3.71B in 2019 at a CAGR of 1.43%. It is forecast to reach about $4.04B in 2025. Austria’s medical devices market was valued at $1.69B in 2015, which increased to $2.03B in 2020 at a CAGR of 3.80%. The medical device market is expected to grow at a CAGR of 1.54% from 2021 to $2.33B in 2025.

The report provides information on the healthcare, regulatory, and reimbursement landscape in Austria, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Bayer, Gerot Lannach, Novartis, Pfizer, and Roche
- Profiles and SWOT analyses of the major players in the medical device market: Boston Scientific, Getinge, Medtronic, Sanochemia Pharmazeutika, and Smith & Nephew
- An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Austria healthcare market

Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Austrian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Austrian healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.